Meta Pixel

News and Announcements

Credi launched Founder Financing Solution for Australian SME’s

  • Published July 24, 2020 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

COVID will double the number of start-ups created annually in Australia, and for the 800,000 small businesses – founders funding will be critical to help with working capital and expansion.

Credi platform manages founders financing, whether via fixed loan amounts or line of credit –  providing agreement, security registration, repayments,  transaction reporting.

To read the full article, click here.

Register Interest

About Credi Pty Ltd

Credi.com is the worlds favourite free online platform for documenting & managing loan agreements between family, friends & related parties. Create, negotiate and e-sign loan agreements in minutes with ease using the Credi loan builder wizard. Bringing clarity, protection, and compliance for the parties to previously informal loans.

Credi is the world’s leading relationship lending platform – managing millions of dollars of lending between friends and family at interest rates a fraction of those offered by the banks.

Credi is uniquely positioned to deliver loans at rates that can change the way people finance their lives, with even small value loans saving thousands of dollars over the loan’s lifetime – retaining and preserving family finances and providing a foundation for saving and superannuation/pension contributions earlier than normally would commence in the financing lifecycle.

Register Interest

 

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now